Arrowstreet Capital, Limited Partnership Jazz Pharmaceuticals PLC Transaction History

Arrowstreet Capital, Limited Partnership

$114 Billion
Q2 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 44,237 shares of JAZZ stock, worth $5.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,237

Holding current value

$5.65 Million

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$103.94 - $118.98 $4.6 Million - $5.26 Million	44,237 New	44,237 $4.72 Million
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $22.7 Million - $27.1 Million	-186,190 Reduced 60.99%	119,101 $15.4 Million
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $29.3 Million - $35.2 Million	-239,249 Reduced 43.94%	305,291 $37.8 Million
Q1 2023 May 15, 2023	SELL	$133.98 - $160.47 $18.8 Million - $22.5 Million	-139,977 Reduced 20.45%	544,540 $79.7 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $23.7 Million - $29.2 Million	182,721 Added 36.41%	684,517 $109 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $62.9 Million - $80.1 Million	497,016 Added 10397.82%	501,796 $66.9 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $676,800 - $806,194	4,780 New	4,780 $746,000
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $2.98 Million - $3.63 Million	-24,900 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $27.4 Million - $39.4 Million	-212,952 Reduced 89.53%	24,900 $3.24 Million
Q2 2021 Aug 13, 2021	BUY	$160.2 - $186.42 $26 Million - $30.2 Million	162,037 Added 213.73%	237,852 $42.3 Million
Q1 2021 May 14, 2021	BUY	$150.19 - $173.5 $11.4 Million - $13.2 Million	75,815 New	75,815 $12.5 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $13 Million - $17.8 Million	-123,397 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$95.68 - $121.88 $2.89 Million - $3.68 Million	-30,167 Reduced 19.64%	123,397 $13.6 Million
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $39.3 Million - $68.4 Million	-447,688 Reduced 74.46%	153,564 $15.3 Million
Q4 2019 Feb 13, 2020	BUY	$117.65 - $153.73 $19.4 Million - $25.4 Million	165,144 Added 37.87%	601,252 $89.8 Million
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $22.2 Million - $25.4 Million	177,048 Added 68.34%	436,108 $55.9 Million
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $6.39 Million - $7.36 Million	-50,935 Reduced 16.43%	259,060 $36.9 Million
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $37.5 Million - $44 Million	307,695 Added 13378.04%	309,995 $44.3 Million
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $6.35 Million - $9.13 Million	-54,767 Reduced 95.97%	2,300 $285,000
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $8.14 Million - $9.13 Million	50,567 Added 777.95%	57,067 $9.6 Million
Q2 2018 Aug 14, 2018	BUY	$146.33 - $183.18 $951,145 - $1.19 Million	6,500 New	6,500 $1.12 Million
Q4 2017 Feb 09, 2018	SELL	$131.06 - $150.39 $2.46 Million - $2.83 Million	-18,800 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $2.68 Million - $2.93 Million	18,800	18,800 $2.75 Million

Others Institutions Holding JAZZ

# of Institutions

503

Shares Held

58.1M

Call Options Held

170K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.01B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Jazz Pharmaceuticals PLC Transaction History